Trial Profile
Aapatinib plus paclitaxel and cisplatin/carboplatin versus paclitaxel and cisplatin/carboplatin in the treatment of stage IVB, recurrent or persistent cervical cancer a prospective, randomized, multicenter, phase II clinical study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Adenocarcinoma; Carcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 10 Sep 2018 New trial record